FDA, Endo Pause Bulk Compounding Lawsuit Pending FDA Guidance

The FDA filed a joint motion with Endo to pause the company’s lawsuit accusing the agency of breaking the law with its decree authorizing bulk compounding of drugs.
Source: Drug Industry Daily